Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE · · 3 pages · Chinese
Release
Hubei Jumpcan Pharmaceutical Co., Ltd on 6ix
Earlier from Hubei Jumpcan Pharmaceutical
- Announcement on Resignation of Non-independent Director and Election of Employee Representative Director
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
- Announcement on the Release of Pledge for Shares Held by the Controlling Shareholder
- Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2025
- Indicative Announcement on the Use of Self-exercise for the 1st Exercise Period of Stock Options of Initial Grant under the 2022 Restricted Stock and Stock Option Incentive Plan
Later from Hubei Jumpcan Pharmaceutical
- Announcement on Lifting Trading Restrictions and Listing of the 1st Trade Restriction Release Period of Initially Granted Restricted Stock under the 2022 Restricted Stock and Stock Option Incentive Plan
- Announcement on Implementation of Independent Exercise in the 1st Exercise Period of Initially Granted Stock Options in 2022 Restricted Stock and Stock Option Incentive Plan
- Report for Q3 2025
- Announcement on Progress in Wholly-owned Subsidiaries Opening Special Settlement Account for Cash Management of Raised Funds and Using Idle Raised Funds for Cash Management
- Announcement on Implementation of Repurchase and Cancellation of Partial Restricted Stocks under 2022 Restricted Stock and Stock Option Incentive Plan
Follow Hubei Jumpcan Pharmaceutical into a list and get an email when it puts out news.
Follow Hubei Jumpcan Pharmaceutical